Sharma, Manmohan
Malhotra, Nipun
Yogavel, Manickam
Harlos, Karl http://orcid.org/0000-0002-7266-4354
Melillo, Bruno http://orcid.org/0000-0002-9708-5287
Comer, Eamon
Gonse, Arthur
Parvez, Suhel http://orcid.org/0000-0002-6318-6506
Mitasev, Branko
Fang, Francis G.
Schreiber, Stuart L. http://orcid.org/0000-0003-1922-7558
Sharma, Amit
Article History
Received: 3 July 2020
Accepted: 24 November 2020
First Online: 12 January 2021
Competing interests
: S.L.S. is a shareholder and serves on the Board of Directors of Jnana Therapeutics; is a shareholder of Forma Therapeutics and Decibel Therapeutics; is a shareholder and advises Kojin Therapeutics, Kisbee Therapeutics and Eikonizo Therapeutics; serves on the Scientific Advisory Boards of Eisai Co., Ltd., Ono Pharma Foundation, Exo Therapeutics, Biogen, Inc. and F-Prime Capital Partners; and the Board of Advisers of the Genomics Institute of the Novartis Research Foundation; and is a Novartis Faculty Scholar. The Broad Institute and Harvard have filed patent applications relating to work described in this manuscript, including “Compounds and Methods for Treating Parasitic Diseases” (PCT/US18/23270, filed on March 20, 2018 and published as WO18/175385), and “Apicomplexan Parasite Inhibition” (unpublished).